SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,830.29 |
| Enterprise Value ($M) | 1,637.65 |
| Book Value ($M) | 467.96 |
| Book Value / Share | 13.90 |
| Price / Book | 3.91 |
| NCAV ($M) | 465.97 |
| NCAV / Share | 13.84 |
| Price / NCAV | 3.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.22 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.36 |
| Current Ratio | 19.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 493.15 |
| Assets | 495.14 |
| Liabilities | 27.18 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Bain Capital Life Sciences Opportunities III, LP | |||
| 13G | Fmr Llc | |||
| 13G/A | Wellington Management Group Llp | |||
| 13G/A | Paradigm Biocapital Advisors LP | 5.04 | -37.23 | |
| 13G | BlackRock, Inc. | 6.20 | 0.00 | |
| 13G | Frazier Life Sciences Public Fund, L.P. | 5.90 | ||
| 13D/A | Ai Dmi Llc | 12.60 | 12.45 | |
| 13D/A | Orbimed Advisors Llc | 6.00 | 4.90 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 3.11 | -35.49 | |
| 13D/A | Atlas Venture Fund X, L.P. | 5.80 | -12.02 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 35,148 | 391,101 | 8.99 | |
| 46,439 | 338,573 | 13.72 | |
| 26,562 | 289,102 | 9.19 | |
| 47,927 | 278,470 | 17.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IKNA – Ikena Oncology, Inc. | IMRX – Immuneering Corporation |
| IOVA – Iovance Biotherapeutics, Inc. | ITOS – iTeos Therapeutics, Inc. |
| IVVD – Invivyd, Inc. |
Financial data and stock pages provided by
Fintel.io